Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs.

New, higher and changing tariffs will ripple through the economy and into share prices for many quarters to come.

U.S. stock earnings have topped expectations and several companies have upped their forecasts, including Disney and Honda Motor.

Prestige Consumer Healthcare expects full-year earnings to be $4.50 to $4.58 per share, with revenue in the range of $1.1 billion to $1.12 billion. This story was generated by Automated Insights ( ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Dentsply expects full-year earnings in the range of $1.80 to $2 per share, with revenue in the range of $3.6 billion to $3.7 billion. This story was generated by Automated Insights ( ...

So far this earnings season, companies in the S&P 500 that miss Wall Street's estimates for earnings per share and sales have ...

With its 4-star rating, we believe Microsoft’s stock is undervalued compared with our long-term fair value estimate of $600 per share, which implies a fiscal 2026 enterprise value/sales multiple of 14 ...

Madison Investments highlights Texas Instruments’ analog dominance and resilient strategy amid tariffs. Discover why they see ...

Robinhood is experiencing robust earnings momentum, expanding its customer base, and making significant moves in the booming ...

Key Points MetLife's adjusted earnings per share (Non-GAAP) fell to $2.02, missed estimates by 6.0% (non-GAAP) and declining 11% from the prior year (non-GAAP, Q2 2025 vs. Q2 2024). Revenue (GAAP) was ...

For its 2025-27 business plan, Mercari aims to achieve double-digit CAGR for revenue, and above 25% CAGR for operating profit. We think the top-line goal seems to be a stretch, but the profit growth ...